TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3714767

Group type: EXPERIMENTAL
Intervention: Atropine sulfate 2 mg/70 kg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Atropine sulfate 4 mg/70 kg
Number of subjects: 10
Study: 29778856

Group type: EXPERIMENTAL
Intervention: Global longitudinal strain (GLS) using 3 apical views
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 4-chamber longitudinal strain (4CV_LS)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 2-chamber longitudinal strain (2CV_LS)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Global longitudinal strain (GLS)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Single-view LS measurements (4CV_LS and 2CV_LS)
Number of subjects: 108
Study: 27476586

Group type: EXPERIMENTAL
Intervention: Multimodal prehabilitation program
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group (higher fitness)
Number of subjects: 106
Study: 24610413

Group type: EXPERIMENTAL
Intervention: Royal jelly supplementation (1,000 mg daily for 8 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (for 8 weeks)
Number of subjects: 50
Study: 23858423

Group type: EXPERIMENTAL
Intervention: Foam plastic insert
Number of subjects: 78

Group type: COMPARATOR
Intervention: No insert (Control)
Number of subjects: 78
Study: 21416590

Group type: EXPERIMENTAL
Intervention: Interactive computer program (IC)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Standard one-on-one genetic counseling
Number of subjects: 44
Study: 18332408

Group type: EXPERIMENTAL
Intervention: Electronic forms on handheld computers
Number of subjects: 60

Group type: COMPARATOR
Intervention: Paper forms
Number of subjects: 60
Study: 16981875

Group type: EXPERIMENTAL
Intervention: Hormonal contraceptive intake phase
Number of subjects: 8

Group type: COMPARATOR
Intervention: HC washout week
Number of subjects: 8
Study: 14609896

Group type: EXPERIMENTAL
Intervention: BD QuikHeel lancet (QH)
Number of subjects: 80

Group type: COMPARATOR
Intervention: BD Safety-Flow lancet (SF)
Number of subjects: 80
Study: 10761763

Group type: EXPERIMENTAL
Intervention: Fludarabine (Flu) 25 mg/m2 for five consecutive days every four weeks
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cladribine (CdA) 0.14 mg/kg for five consecutive days every four weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cladribine (CdA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fludarabine (Flu)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cross-over treatment after failure
Number of subjects: 60
Study: 8848318

Group type: EXPERIMENTAL
Intervention: Functional neuromuscular stimulation (FNS) hand system
Number of subjects: 5

Group type: COMPARATOR
Intervention: Tenodesis
Number of subjects: 5
Study: 1407981

Group type: EXPERIMENTAL
Intervention: Topical medication and/or laser trabeculoplasty
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Fistulizing surgery
Number of subjects: 30

Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 30
Study: 6726903

Group type: EXPERIMENTAL
Intervention: Preoperative radiation therapy (1,600 rad for 4 days)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Contemporary surgery without preoperative radiation therapy
Number of subjects: 197
Study: 31285924

Group type: EXPERIMENTAL
Intervention: Bipolar transurethral resection (B‐TURBT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Monopolar transurethral resection (M‐TURBT)
Number of subjects: 80
Study: 30509743

Group type: EXPERIMENTAL
Intervention: 100 μg/kg oral morphine sulphate
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 27063315

Group type: EXPERIMENTAL
Intervention: Fixed Twin-Block combined with fixed appliance
Number of subjects: 31

Group type: COMPARATOR
Intervention: Fixed appliance after tooth extraction
Number of subjects: 31
Study: 24856057

Group type: EXPERIMENTAL
Intervention: Oxytocin nasal spray (20 international units)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 23768677

Group type: EXPERIMENTAL
Intervention: STOP IT program (integrated treatment for PTSD and smoking)
Number of subjects: 6
Study: 20805642

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone
Number of subjects: 133

Group type: COMPARATOR
Intervention: Control (no intravenous methylprednisolone)
Number of subjects: 133
Study: 18493088

Group type: EXPERIMENTAL
Intervention: Wheelchair (WCL)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Able-bodied (ABL)
Number of subjects: 113
Study: 15928250

Group type: EXPERIMENTAL
Intervention: DHEA (100 mg/d)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: APZ (0.5 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: DHEA and APZ in combination
Number of subjects: 15
Study: 12181240

Group type: EXPERIMENTAL
Intervention: 5-FU plus cisplatin (FUP) - continuous 5-FU 1000 mg/m2/day for 5 days plus cisplatin 100 mg/m2 on day 1 or day 2
Number of subjects: 207

Group type: COMPARATOR
Intervention: 5-FU (FU) - 5-FU 500 mg/m2/day for 5 days
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: 5-FU plus cisplatin (FUP)
Number of subjects: 207

Group type: COMPARATOR
Intervention: 5-FU (FU)
Number of subjects: 207
Study: 10600332

Group type: EXPERIMENTAL
Intervention: ALLERVAX CAT (750 microg/dose)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: ALLERVAX CAT
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 8635183

Group type: EXPERIMENTAL
Intervention: L-deprenyl (10 mg daily) as an adjunct to low-dose bromocriptine (up to 25 mg daily)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Bromocriptine alone
Number of subjects: 21

Group type: COMPARATOR
Intervention: Bromocriptine plus placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: L-deprenyl plus bromocriptine
Number of subjects: 21
Study: 2126361

Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/kg BW in an i.v. bolus)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms in a single oral dose)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Insulin (0.15 IU/kg BW in an i.v. bolus)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: TRH (200 micrograms in an i.v. bolus)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Normal saline (control test)
Number of subjects: 14
Study: 832432

Group type: COMPARATOR
Intervention: NaCl supplements of 200 mEq/day
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Daily mixture of NaHCO3 (100 mEq) and NaCl (100 mEq)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: NaHCO3
Number of subjects: 6
Study: 31834062

Group type: EXPERIMENTAL
Intervention: Therapist-guided online F-PST
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Self-guided online F-PST
Number of subjects: 150

Group type: COMPARATOR
Intervention: Face-to-face F-PST
Number of subjects: 150
Study: 30723316

Group type: EXPERIMENTAL
Intervention: Citalopram (dose-dependent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citalopram (high dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citalopram (low dose)
Number of subjects: 0
Study: 28723597

Group type: EXPERIMENTAL
Intervention: Intra tympanic Gentamicin (40 mgs/ml)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intra tympanic Dexamethasone (0.5 ml, 4 mgs/ml)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Intra tympanic Normal Saline (0.5 ml)
Number of subjects: 60
Study: 26036257

Group type: EXPERIMENTAL
Intervention: Whey extensively hydrolysed formulas (eHF)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Casein extensively hydrolysed formulas (eHF)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Amino acid-based formulas (AAFs)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 150
Study: 23942156

Group type: EXPERIMENTAL
Intervention: Brief mindfulness induction
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 63
Study: 22193396

Group type: EXPERIMENTAL
Intervention: Intracoronary delivery of 100 million bone marrow mononuclear cells (BMMC) through the anterograde route (IAC)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Retrograde intravenous delivery of 100 million bone marrow mononuclear cells (BMMC) through the IVC route
Number of subjects: 30
Study: 19807950

Group type: EXPERIMENTAL
Intervention: iPod users
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conference attendees
Number of subjects: 30
Study: 16331696

Group type: EXPERIMENTAL
Intervention: Radial access (RA) during coronary angiograms
Number of subjects: 297

Group type: COMPARATOR
Intervention: Femoral access (FA) during coronary angiograms
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Radial access (RA) during coronary interventions
Number of subjects: 297

Group type: COMPARATOR
Intervention: Femoral access (FA) during coronary interventions
Number of subjects: 297
Study: 15187836

Group type: EXPERIMENTAL
Intervention: Reamed nailing
Number of subjects: 82

Group type: COMPARATOR
Intervention: Nonreamed nailing
Number of subjects: 82
Study: 11040903

Group type: EXPERIMENTAL
Intervention: Digital colour photography
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Oral fluorescein angiography (OFA)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Standard seven-field stereo photography (gold standard)
Number of subjects: 37
Study: 9074574

Group type: EXPERIMENTAL
Intervention: Compression stockings
Number of subjects: 194

Group type: COMPARATOR
Intervention: No stockings (control)
Number of subjects: 194
Study: 8378945

Group type: EXPERIMENTAL
Intervention: Ticlopidine 250 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin 650 mg twice daily
Number of subjects: 0
Study: 3757511

Group type: EXPERIMENTAL
Intervention: High dose regimen (400 mg/day RU 486 X 4 days or 200 mg/day X 4 days)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Medium dose regimen (100 mg/day X 7 days)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All treatment groups (including both high and medium doses)
Number of subjects: 60
Study: 29667507

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (breathing exercises)
Number of subjects: 30
Study: 30285825

Group type: EXPERIMENTAL
Intervention: Flexible procedure for recruitment and retention of male prison leavers in trials
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Follow-up interview 2-8 weeks after release
Number of subjects: 243

Group type: EXPERIMENTAL
Intervention: Mental health outcomes data collection at baseline and follow-up
Number of subjects: 243
Study: 27323445

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (Zhongwan, Tianshu, Daheng, Daimai, Shuidao, Waiguan, Zulinqi with electroacupuncture stimulation at 2 Hz/100 Hz, 4‐8 mA for 20 min, once every other day for 8 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Health education (restraining wine or liquor and salt intake, stopping smoking, increasing physical activities, regular daily life habit)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 73
Study: 24413724

Group type: EXPERIMENTAL
Intervention: Sleep hygiene training program (1 month, 6 sessions)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 82
Study: 23342615

Group type: EXPERIMENTAL
Intervention: Silodosin 8 mg once daily for 12 weeks
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg once daily for 12 weeks
Number of subjects: 955

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: Silodosin
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: Tamsulosin
Number of subjects: 955
Study: 20687837

Group type: EXPERIMENTAL
Intervention: 50 mg of arterolane once daily for 7 days
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 100 mg of arterolane once daily for 7 days
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: 200 mg of arterolane once daily for 7 days
Number of subjects: 230
Study: 18984430

Group type: EXPERIMENTAL
Intervention: Indapamide (IND) 2.5 mg once daily
Number of subjects: 23

Group type: COMPARATOR
Intervention: Bendroflumethiazide (BDZ) 2.5 mg once daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Pooled data from both groups
Number of subjects: 23
Study: 15836686

Group type: EXPERIMENTAL
Intervention: AAI-guided sevoflurane titration (target = 20 +/- 5)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Clinical signs-guided sevoflurane titration
Number of subjects: 100
Study: 11918749

Group type: EXPERIMENTAL
Intervention: L-Arg supplementation (IV for three days)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: L-Arg administration
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (sham operated animals)
Number of subjects: 54
Study: 10341399

Group type: EXPERIMENTAL
Intervention: Combination of maternal age, fetal nuchal translucency thickness, maternal serum free beta‐hCG, and PAPP‐A
Number of subjects: 1156

Group type: COMPARATOR
Intervention: Nuchal translucency and maternal age alone
Number of subjects: 1156
Study: 8730942

Group type: EXPERIMENTAL
Intervention: Dothiepin (150 mg/day)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Dothiepin
Number of subjects: 87
Study: 1919421

Group type: EXPERIMENTAL
Intervention: Boiled coffee (BC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Filtered boiled coffee (BFC)
Number of subjects: 20
Study: 7066935

Group type: EXPERIMENTAL
Intervention: Diazemuls (lipid emulsion)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Valium
Number of subjects: 109
Study: 30953552

Group type: EXPERIMENTAL
Intervention: Sustained home visiting (MECSH)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 41
Study: 28322414

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (n=100)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group (sedation without dexmedetomidine; n=101)
Number of subjects: 201
Study: 23672237

Group type: EXPERIMENTAL
Intervention: Cilostazol (100 mg orally twice daily for 24 weeks)
Number of subjects: 78

Group type: COMPARATOR
Intervention: No cilostazol (Group A without claudication)
Number of subjects: 78
Study: 23846810

Group type: EXPERIMENTAL
Intervention: Benchmarking group (standard care with feedback benchmarked against other centers)
Number of subjects: 4027

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 4027

Group type: EXPERIMENTAL
Intervention: Benchmarking group
Number of subjects: 4027

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4027
Study: 21594960

Group type: EXPERIMENTAL
Intervention: ALDH(br) cells
Number of subjects: 21

Group type: COMPARATOR
Intervention: ABMMNCs
Number of subjects: 21

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 21
Study: 18401699

Group type: EXPERIMENTAL
Intervention: Cotrimoxazole
Number of subjects: 496

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 496
Study: 15968883

Group type: EXPERIMENTAL
Intervention: Ciclesonide (640 microg ex‐actuator, equivalent to 800 microg ex‐valve, via hydrofluoroalkane metered‐dose inhaler)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Erythromycin (500 mg PO)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Combined administration of ciclesonide and erythromycin
Number of subjects: 18
Study: 12056936

Group type: EXPERIMENTAL
Intervention: Civamide (100 microL of 0.025% civamide, 25 microg) once daily for 7 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Vehicle (100 microL) once daily for 7 days
Number of subjects: 28
Study: 10844404

Group type: EXPERIMENTAL
Intervention: Danaparoid
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Dalteparin
Number of subjects: 197
Study: 8708510

Group type: EXPERIMENTAL
Intervention: Paclitaxel 135 mg/m2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel 250 mg/m2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel (both doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel (high dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 0
Study: 1746996

Group type: EXPERIMENTAL
Intervention: Famotidine 20 mg BID
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg HS
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg HS and Famotidine 20 mg BID
Number of subjects: 338

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 338
Study: 6213641

Group type: EXPERIMENTAL
Intervention: Preparation (informative preoperative interview)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo (reassuring preoperative interview)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (no contact prior to surgery)
Number of subjects: 59
Study: 30823947

Group type: EXPERIMENTAL
Intervention: LISA (less invasive surfactant administration)
Number of subjects: 100

Group type: COMPARATOR
Intervention: INSURE (INtubation SURfactant administration and Extubation)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: LISA
Number of subjects: 100

Group type: COMPARATOR
Intervention: INSURE
Number of subjects: 100
Study: 27973989

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (SB) plus Amoxicillin-Clavulanate (AC)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Amoxicillin-Clavulanate (AC) alone
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Saccharomyces boulardii (SB) alone
Number of subjects: 4
Study: 26108607

Group type: EXPERIMENTAL
Intervention: EVG/COBI/FTC/TDF
Number of subjects: 18
Study: 23930929

Group type: EXPERIMENTAL
Intervention: Brown rice (BR)
Number of subjects: 27

Group type: COMPARATOR
Intervention: White rice (WR)
Number of subjects: 27
Study: 21494229

Group type: EXPERIMENTAL
Intervention: Calorie-reduced, low-fat diet (D)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Moderate-intensity, facility-based aerobic exercise program (E)
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Combination of diet and exercise (D+E)
Number of subjects: 439

Group type: COMPARATOR
Intervention: No-lifestyle-change control (C)
Number of subjects: 439
Study: 19466657

Group type: EXPERIMENTAL
Intervention: Total thyroidectomy or near-total thyroidectomy (group A)
Number of subjects: 346

Group type: COMPARATOR
Intervention: Partial or subtotal thyroid gland removal treatment (group B)
Number of subjects: 346
Study: 17224198

Group type: EXPERIMENTAL
Intervention: 10 Swiss Francs incentive
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 20 Swiss Francs incentive
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 30 Swiss Francs incentive
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: No reward
Number of subjects: 44
Study: 15915304

Group type: EXPERIMENTAL
Intervention: Early laminectomy in cauda equina syndrome secondary to lumbar disc herniation
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Discectomy or microdiscectomy
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Fusion surgery (probably non-instrumented)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Discectomy
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Surgery for discogenic pain
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conservative therapies
Number of subjects: 44
Study: 12360380

Group type: EXPERIMENTAL
Intervention: Intraperitoneal pethidine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intramuscular pethidine
Number of subjects: 100
Study: 9615847

Group type: EXPERIMENTAL
Intervention: Preoperative ketoprofen 100 mg i.v., 12 mg/h during surgery and for 48 hours afterwards
Number of subjects: 81

Group type: COMPARATOR
Intervention: 100 mg ketoprofen as a bolus injection before the end of surgery, thereafter 12 mg/h ketoprofen continuously for 48 hours
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo during surgery and for 48 hours after surgery
Number of subjects: 81
Study: 8714503

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (20 mg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Diltiazem (60 mg)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg)
Number of subjects: 28
Study: 2693686

Group type: EXPERIMENTAL
Intervention: Transcendental Meditation (TM) program
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Mindfulness training (MF)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Relaxation (low mindfulness) program
Number of subjects: 73

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 73
Study: 338092

Group type: EXPERIMENTAL
Intervention: One-layer technique of suture
Number of subjects: 137

Group type: COMPARATOR
Intervention: Two-layer technique of suture
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Clinical diagnosis of anastomotic leakage
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Radiological examination for subclinical dehiscence
Number of subjects: 137
Study: 31184670

Group type: EXPERIMENTAL
Intervention: Random patchy particles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Homogeneous (isotropic) particles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heterogeneous colloids
Number of subjects: 0
Study: 25811297

Group type: EXPERIMENTAL
Intervention: Sentinel Web-application for self-assessed symptoms reporting, with real-time data processing and alerts to oncologists.
Number of subjects: 98

Group type: COMPARATOR
Intervention: Conventional follow-up (visit and imaging every 2 to 6 months).
Number of subjects: 98
Study: 24832384

Group type: EXPERIMENTAL
Intervention: Extended-release niacin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended-release niacin/laropiprant
Number of subjects: 0
Study: 23809454

Group type: EXPERIMENTAL
Intervention: All-inside ACL reconstruction
Number of subjects: 150

Group type: COMPARATOR
Intervention: Full-tibial tunnel ACL reconstruction
Number of subjects: 150
Study: 22104549

Group type: EXPERIMENTAL
Intervention: Left Ventricular (LV) pacing
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Biventricular (BiV) pacing
Number of subjects: 121
Study: 19486449

Group type: EXPERIMENTAL
Intervention: Pantoprazole (40 mg/day) for 28 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ranitidine (300 mg o.d.) for 60 days
Number of subjects: 60